Development of Resistance Mutations in Women Receiving Standard Antiretroviral Therapy Who Received Intrapartum Nevirapine to Prevent Perinatal Human Immunodeficiency Virus Type 1 Transmission: A Substudy of Pediatric AIDS Clinical Trials Group Protocol 316
Coleen K. Cunningham(Duke Medical Center), John L. Sullivan, Marie‐Laure Chaix(Institut de Virologie), Alejandro Dorenbaum(University of California, San Francisco), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Christine Rouzioux(Université Paris Cité), Jean François Delfraissy(Bicêtre Hospital), Brigitte Bazin(Agence Nationale de Recherches sur le Sida et les Hépatites Virales), Claire Rekacewicz(Inserm), Paula Britto(Cancer Research And Biostatistics), Richard D. Gelber(Harvard University)
Cited by 136
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k